AKAM
56
-2
HRL
38
2
MS
50
-8
HSIC
56
3
SWK
80
2
KMI
59
2
CHD
53
-3
PPL
60
-7
AMGN
55
-2
RIG
35
-3
STX
53
-4
AMAT
49
-3
AIZ
71
-2
BLK
69
2
STZ
54
-4
SE
65
4
BWA
42
-2
EMN
70
-2
AVY
54
-14
PNR
72
-2
AKAM
56
-2
HRL
38
2
MS
50
-8
HSIC
56
3
SWK
80
2
KMI
59
2
CHD
53
-3
PPL
60
-7
AMGN
55
-2
RIG
35
-3
STX
53
-4
AMAT
49
-3
AIZ
71
-2
BLK
69
2
STZ
54
-4
SE
65
4
BWA
42
-2
EMN
70
-2
AVY
54
-14
PNR
72
-2
Financhill
Back

Digital World Acquisition Vs. Biomarin Pharmaceutical Industry Stock Comparison

Sell
34

DWAC
Digital World Acquisition

Last Price:
17.97
Seasonality Move:
-4.02%
Sell
33

BMRN
Biomarin Pharmaceutical

Last Price:
71.46
Seasonality Move:
5.7%
Sell
34
Digital World Acquisition (DWAC) is a Sell

Is Digital World Acquisition a Buy, Sell or Hold?

  • The current Digital World Acquisition [DWAC] share price is $15.62. The Score for DWAC is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
  • DWAC is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
33
Biomarin Pharmaceutical (BMRN) is a Sell

Is Biomarin Pharmaceutical a Buy, Sell or Hold?

  • The current Biomarin Pharmaceutical [BMRN] share price is $71.14. The Score for BMRN is 33, which is 34% below its historic median score of 50, and infers higher risk than normal.
  • BMRN is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

DWAC Stock Price Chart

What is Digital World Acquisition's stock price today?

  • The Digital World Acquisition share price today is $15.62
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and DWAC is experiencing slight selling pressure.

BMRN Stock Price Chart

What is Biomarin Pharmaceutical's stock price today?

  • The Biomarin Pharmaceutical share price today is $71.14
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BMRN is experiencing slight buying pressure.

DWAC Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -2.5 Sell
Relative Strength Index (14 RSI): 31.98 Sell
Chaikin Money Flow: -3634247 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (16.96 - 22.4) Sell
Bollinger Bands (100): (22.51 - 45.25) Sell

BMRN Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -3.61 Sell
Relative Strength Index (14 RSI): 22.64 Sell
Chaikin Money Flow: 871265 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (80.02 - 93.28) Sell
Bollinger Bands (100): (78.57 - 88.29) Sell

DWAC Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 17.05 Sell
20-day SMA: 18.89 Sell
50-day SMA: 25.08 Sell
200-day SMA: 34.01 Sell
8-day EMA: 16.93 Sell
20-day EMA: 18.94 Sell
50-day EMA: 24.1 Sell
200-day EMA: 30.18 Sell

BMRN Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 79.35 Sell
20-day SMA: 85.57 Sell
50-day SMA: 85.93 Sell
200-day SMA: 87.02 Sell
8-day EMA: 77.71 Sell
20-day EMA: 82.86 Sell
50-day EMA: 84.86 Sell
200-day EMA: 86.16 Sell

Digital World Acquisition Earnings Growth & DWAC Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Biomarin Pharmaceutical Earnings Growth & BMRN Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.31 per share, an increase next quarter of $0.29 per share, an increase this year of $1.19 per share, and an increase next year of $1.04 per share.

Digital World Acquisition Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Biomarin Pharmaceutical Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):